Stage FocusSeed, Series A, Series B+
GeographyUS
TypeVC
Last Activity2025
Industry Focus
Industries
BiotechMedtechAI
Technical BenchStrong
Investor TypeDeepTech Specialist
ExposureMostly DeepTech Investments
Bio
Foresite Capital, founded in 2011 by Jim Tananbaum MD, manages $3.5B-plus—making it one of the largest dedicated healthcare and life sciences VCs. Fund VI closed at $900M in June 2024. Check sizes range from $2M to $75M, backing approximately 20 companies per fund through the full investment lifecycle.
The portfolio demonstrates deep tech conviction in genomics and precision medicine: 10x Genomic...
Notable Investments
1
10x GenomicsR
Relay TherapeuticsV
VaxcyteJ
Juno TherapeuticsI
Intellia TherapeuticsP
Pacific BiosciencesQ
Quantum-SISimilar Funds
ARTIS Ventures
San Francisco, United States
DeepTech NativeBiotechAIMedtechSeedSeries A
Osage University Partners
Bala Cynwyd, United States
DeepTech NativeBiotechMedtechClimate TechSeedSeries A
Section 32 (S32)
Palo Alto, United States
DeepTech NativeBiotechMedtechAISeedSeries A
Abingworth
London, United Kingdom
DeepTech NativeBiotechMedtechSeedSeries A
Agent Capital
Waltham, United States
DeepTech NativeBiotechMedtechNeurotechSeedSeries A
Ahren Innovation Capital
London, United Kingdom
DeepTech NativeBiotechRoboticsClimate TechSeedSeries A